Member Info for dactions

Whatever his expertise, as a lth myself, I wouldn’t mind seeing 3p again after all these years :)

I didn’t see any RNS until 8.36 this morning by which time I presume Boots cleaned up their website. Disappointing that MHC claimed that negotiations were still in progress - not a good look between the two companies - perhaps Boots are playing hardball with MHC. Might explain why this retail link has been so slow coming with these so-called new products.

It’s not as if the shareprice reacted much in any case. Looks like we’ve got a long wait still before this sp moves :(

"Can easy be glass half empty with MHC ... so if we go glass half full"

Unfortunately for us LTHs, without some news, the sp isn't going anywhere, but I like the image of your ducks doing the towing.

Last Sunday Mail 'City Whispers' column was headed ' Erectile dysfunction firm is hoping to boost its mojo'.

Whilst nothing new for LTHs in the article, it reckons Furtura could be on course for global domination and points out that the US is the next big goal and after that the focus will turn more to Asia. It concludes " Perhaps this will provide a longer-lasting rise in the shares, as a 26% spike in the wake of the UK launch has lost steam".

All good publicity in my opinion.

Thanks Bluerill for HSR bulletin. How good it is to be seeing positive news and opinions after all these years.

This morning’s RNS makes the deal so much clearer - not sure why it couldn’t have been included last Friday. It’s good to see it back in trading and the initial contracts look almost too good to be true - as quoted by Brill.

So if it opens late May at above 55p then I’ll be very happy.

I've just ploughed through tonight's very lengthy RNS and frankly I can't make much sense of it - or at least as far as Fox shareholders are concerned. It seems like a very nice gravy train for the new crew with plenty of options for each one but no mention of Fox shareholders other than it seems the shares are going to be watered down substantially.

Chris Gilbart - most of us have been with you as shareholders for years - are you shafting us after all this time ??

The consensus following the results announcement seems to be 'sort of' positive - in that there is a plan to be kicked off sometime in H2. Some have interpreted that there are 'hidden' positives which will all become clear - just wait a little longer. They may be right but as shareholders we can't really weigh up the pros and cons , least of all these hidden ones !

Apart from us all looking in wonder when the spouse of Brooke Clarke bought 8,520 shares 28th January 2022 at 189.717p, why do we never see any other Senior Management/Director buy Synairgen shares ? If ever there was a need to believe in Richard Marsden's plan, real or otherwise, now is the time to instill confidence in the Company with their own money.

What do others think ?

RNS today announces they reduced their holding last Thursday by a little under 3million shares. The sp held up well in the circumstances - most of those shares would have been obtained in the 7p placing some years back so a nice book profit.

Effectively we have had radio silence from RM since February last year - what little that has come out, notably at last year's agm has been laughable in it's paucity.

As one who met and spoke personally with RM several times when he was doing the rounds at the many investor shows, it was clear to me that he lived and breathed Synairgen and his enthusiasm was contagious. Consequently, I over-invested and never took any profits on the way up because of his enthusiastic personality. I have a colossal loss.

I would dearly love there to be some positive conclusion or announcement next week but on the experience of these past 12 months I am not hopeful. If that is the case, if I were RM, the honourable thing would be to resign and let others shake out a path that promotes the undoubted benefits that I believe SNG001 does possess.

Ecologist - I think you'll find that is a Belgian pharmacy business but language is French. And as for discounts - at the current high product selling price, a discount isn't really a problem - it's early days for Cooper in assessing what the market will bear in price.

"I should think next country might be Belgium"

What's your thinking on this BruceJamieson as Belgium is already selling Eroxon ?

kdonkey - good point about the patent extension - that would in itself prove to be a very likely large increase in the SP.

I would have liked to see the sp higher at this stage - at least around the 75p level based on the strong indications after the Belgium launch. Remember it's been a whole 2 years since we had the approx 85p spike following the announcement of the CE marking. It then fell back relatively quickly to around 50p and stabilised there for a while - now we're at last back to those levels. Unfortunately, Barder's always been playing a long game - whether that's by accident or design (I think accident) and he'll believe he's been right all the way along. Remember he has a very large shareholding, never mind his options.

In my opinion, we will definitely see another spike once the FDA approves it as an OTC product but the fact that the sp is where it is now means the sp will only respond in future to actual details of sales - something I don't think we'll get for a good while.

I first purchased FUM over 10 years ago but around 60p - fortunately I bought in again when they did the 7p placing which Lombard Odier supported big time - but I think we still have to be patient as to sp growth if FUM stays independent. The quickest way we'll do really well with FUM is, in my opinion, a buyout - something I'm hoping for.

I can't agree on the Consolidation - it's the wrong move right now - experience of other consolidations have all been negative in the early phases as large holders take advantage of the better initial marketability of the stock.

If only the BoD took onboard that the real problems are lack of regular updates on what is going on in Marketing/contracts with the likes of Boots etc. There is effectively nothing concrete being announced.

It’s a complex RNS today no doubt about that. Once again though the big positive is the speedy updates that Paul Dolan announces. And at last great news of the 50000 hectares the Gabon government has made available to start the carbon capture project which will be self financing. It’s success will lead to more business.

Woodbois has shown that it can be a trusted partner in Gabon and will continue to grow this much needed business that provides employment and social cohesion.

Jamrock - I don’t know who you’re confusing me with but I’ve said none of the things you accuse me of. You’ve been constantly ramping this share despite it falling in value by a huge percentage. Frankly your arguments to justify this are ridiculous.

You apparently have multi-millions of shares and have never sold any and yet your current average is close to the current low. I would have thought your average is more likely to be above 2p meaning you are nursing losses of many, many tens of thousands of pounds.

Let’s keep our analysis of MHC rational and not be blinded by wishful thinking.

Jamrock - your repeated comments are like a broken record - sometimes it’s better to let time go by without resorting to daily ramping.

I’ve analysed why the shareprice is where it is- and that’s because ‘saint’ Penny is not performing as you keep telling us she is. The message we hear from her has changed (ie last June’s launch of 5 wellness products we now learn we’re only a ‘Soft Launch’). Her ‘excited’ intention to tell us of yet newer products in 2022 4th quarter never happened.

These are the reasons why the SP is so low. Massaging the message and missing inferred deadlines are not attributes of a great CEO unfortunately for us.

Given the current launch & trading - the past year’s results are rather academic except the last line where they said the cash runway was good for this year effectively.

What would they need the cash for- surely Coopers will be remitting sales funds to FUM ?